Comparison of TGF-β, PDGF, and CTGF in hepatic fibrosis models using DMN, CCl₄, and TAA

References

• Abou-Shady M, Friess H, Zimmermann A, et al. (2000). Connective tissue growth factor in human liver cirrhosis. Liver 20:296–304
   PubMedGoogle Scholar
• Brunt EM, Janney CG, Di Bisceglie AM, et al. (1999). Nonalcoholic steatohepatitis: a proposal for grading and staging the 563 histological lesions. Am J Gastroenterol 94:2467–2474
   PubMed Web of Science ®Google Scholar
• Cheong JY, Kim DJ, Hwang SG, et al. (2011). Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels. Liver Int 31:1352–1358
   PubMed Web of Science ®Google Scholar
• Domenicali M, Caraceni P, Giannone F, et al. (2009). Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. Gastroenterology 137:341–349
   PubMed Web of Science ®Google Scholar
• Faiz KUAA, Ohtani H, Nio M, et al. (2000). In situ expression of fibrogenic growth factors and their receptors in biliary atresia: comparison between early and late stages. J Pathol 192:73–80
   PubMed Web of Science ®Google Scholar
• Friedman SL. (2003). Liver fibrosis – from bench to bedside. J Hepatol 38:S38–S53
   PubMed Web of Science ®Google Scholar
• Friedman SL. (2008). Mechanisms of hepatic fibrogenesis. Gastroenterology 134:1655–1669
   PubMed Web of Science ®Google Scholar
• Fujita M, Shannon JM, Morikawa O, et al. (2003). Overexpression of tumor necrosis factor-alpha diminishes pulmonary fibrosis induced by bleomycin or transforming growth factor-beta. Am J Respir Cell Mol Biol 29:669–676
   PubMed Web of Science ®Google Scholar
• George J. (2006). Mineral metabolism in dimethylnitrosamine-induced hepatic fibrosis. Clin Biochem 39:984–991
   PubMed Web of Science ®Google Scholar
• George J, Chandrakasan G. (1996). Glycoprotein metabolism in dimethylnitrosamine induced hepatic fibrosis in rats. Int J Biochem Cell Biol 28:353–361
   PubMed Web of Science ®Google Scholar
• George J, Chandrakasan G. (2000). Biochemical abnormalities during the progression of hepatic fibrosis induced by dimethylnitrosamine. Clin Biochem 33:563–570
   PubMed Web of Science ®Google Scholar
• George J, Rao KR, Stern R, Chandrakasan G. (2001). Dimethylnitrosamine-induced liver injury in rats: the early deposition of collagen. Toxicology 156:129–138
   PubMed Web of Science ®Google Scholar
• Gressner OA, Gressner AM. (2008). Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Liver Int 28:1065–1079
   PubMed Web of Science ®Google Scholar
• Hora C, Negro F, Leandro G, et al. (2008). Connective tissue growth factor, steatosis and fibrosis in patients with chronic hepatitis C. Liver Int 28:370–376
   PubMed Web of Science ®Google Scholar
• Iredale JP. (2007). Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117:539–548
   PubMed Web of Science ®Google Scholar
• Jang JH, Kang KJ, Kim YH, et al. (2008). Reevaluation of experimental model of hepatic fibrosis induced by hepatotoxic drugs: an easy, applicable, and reproducible model. Transplant Proc 40:2700–2703
   PubMed Web of Science ®Google Scholar
• Kisseleva T, Brenner DA. (2006). Hepatic stellate cells and the reversal of fibrosis. J Gastroenterol Hepatol 21:S84–S87
   PubMed Web of Science ®Google Scholar
• Kochanek KD, Xu JQ, Murphy SL, et al. Deaths: preliminary data for 2009. National vital statistics reports. Vol. 59. No. 4. Hyattsville (MD): National Center for Health Statistics; 2011
   Google Scholar
• Lee UE, Friedman SL. (2011). Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol 25:195–206
   PubMed Web of Science ®Google Scholar
• Leon DA, Mccambridge J. (2006). Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data. Lancet 367:52–56
   PubMed Web of Science ®Google Scholar
• Mihara M, Uchiyama M. (1978). Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86:271–278
   PubMed Web of Science ®Google Scholar
• Natarajan SK, Thomas S, Ramamoorthy P, et al. (2006). Oxidative stress in the development of liver cirrhosis: a comparison of two different experimental models. J Gastroenterol Hepatol 21:947–957
   PubMed Web of Science ®Google Scholar
• Panduro A, Shalaby F, Biempica L, Shafritz DA. (1988). Changes in albumin, alpha-fetoprotein and collagen gene transcription in CCl4-induced hepatic fibrosis. Hepatology 8:259–266
   PubMed Web of Science ®Google Scholar
• Parola, M, Robino, G. (2001). Oxidative stress-related molecules and liver fibrosis. J Hepatol 35:297–306
   PubMed Web of Science ®Google Scholar
• Poli G. (2000). Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 21:49–98
   PubMedGoogle Scholar
• Poynard T, Lebray P, Ingiliz P, et al. (2010). Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest). BMC Gastroenterol 10:40
   PubMed Web of Science ®Google Scholar
• Sahin T, Begec Z, Toprak Hİ, et al. (2013). The effects of dexmedetomidine on liver ischemia-reperfusion injury in rats. J Surg Res 183:385–390
   PubMed Web of Science ®Google Scholar
• Salguero Palacios R, Roderfeld M, Hemmann S, et al. (2008). Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice. Lab Invest 88:1192–1203
   PubMed Web of Science ®Google Scholar
• Tsukada S, Parsons CJ, Rippe RA. (2006). Mechanisms of liver fibrosis. Clin Chim Acta 364:33–60
   PubMed Web of Science ®Google Scholar
• Tsukamoto H, Matsuoka M, French SW. (1990). Experimental models of hepatic fibrosis: a review. Semin Liver Dis 10:56–65
   PubMed Web of Science ®Google Scholar
• Wang XB, Feng Y, Wang N, et al. (2012). Recent progress on anti-liver fibrosis candidates in patents of herbal medicinal products. Recent Pat Food Nutr Agric 4:91–106
   PubMedGoogle Scholar
• Wang Y, Gao J, Zhang D, et al. (2010). New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. J Hepatol 53:132–144
   PubMed Web of Science ®Google Scholar
• Weber SN, Wasmuth HE. (2010). Liver fibrosis: from animal models to mapping of human risk variants. Best Pract Res Clin Gastroenterol 24:635–646
   PubMed Web of Science ®Google Scholar
• Weng HL, Liu Y, Chen JL, et al. (2009). The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis. Hepatology 50:230–243
   PubMed Web of Science ®Google Scholar
• Wight TN, Potter-Perigo S. (2011). The extracellular matrix: an active or passive player in fibrosis? Am J Physiol Gastrointest Liver Physiol 301:G950–G955
   PubMed Web of Science ®Google Scholar
• Wisse E, Jacobs F, Topal B, et al. (2008). The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer. Gene Ther 15:1193–1199
   PubMed Web of Science ®Google Scholar